How An MBA Is Scaling A Medical Technology StartupPartner Content by: Johns Hopkins Carey Business School on November 20, 2026 | 5 minute read November 20, 2026 Copy Link Share on Facebook Share on Twitter Email Share on LinkedIn Share on WhatsApp Share on Reddit When Full-time MBA student, Juan Fernandez arrived at Johns Hopkins Carey Business School in 2023, he brought more than an entrepreneurial idea. He brought a medical technology company already tested in clinical settings and a new challenge: figuring out how to scale it in the United States. His startup, SmartTIVA Inc., grew from a problem he saw while developing medical technologies in Colombia. Anesthesia is a high-stakes, data-rich part of surgery, yet dosing is still largely manual and can vary from patient to patient. SmartTIVA is developing technology that uses signals such as Electroencephalogram, or EEG, to help clinicians personalize anesthesia delivery in real time. The company had developed, validated, and used its system clinically in Colombia. SmartTIVA initially developed its EEG simulator internally for testing, but customer discovery in the United States revealed a broader market need for the tool. Moving into the United States market meant navigating new regulations, building a local network, and creating a commercial strategy. Fernandez says Carey helped him tackle those business challenges alongside his Full-time MBA. FROM CLINICAL TECHNOLOGY TO A U.S. BUSINESS PLAN SmartTIVA’s goal is to improve patient safety through more precise anesthesia dosing. Its closed-loop technology helps clinicians adjust medication based on patient signals, with the potential to reduce complications and support opioid-free anesthesia. The company is also developing Sedsim, a simulation tool for training clinicians in brain monitoring, alongside products including SmartTIVA View and SmartKIT. A turning point in SmartTIVA’s U.S. planning came through Carey’s Innovations for Substance Use Disorders program in 2024. Fernandez and his team used the program to structure the company’s business plan, refine its commercialization strategy, and develop its opioid-free anesthesia offering. The work also helped lay the foundation for applications to Small Business Innovation Research, or SBIR, funding programs through the National Institutes of Health and National Science Foundation. With support from the Pava Center and related programs, SmartTIVA has received mentorship and support with pitching, funding opportunities, and commercialization. Carey’s MBA coursework has also helped Fernandez apply business concepts to immediate startup needs. Students have worked on SmartTIVA’s marketing plan, while projects in finance, business law, and negotiation have addressed challenges facing the company. SmartTIVA has sponsored a business communication class and is preparing to sponsor a venture capital and angel investing class. For Fernandez, that connection between classroom and company is part of the value. Students get to work with a real startup, while SmartTIVA can put new ideas and skills to use. A STARTUP GROWS THROUGH RELATIONSHIPS Building a medical technology company takes more than an effective product. SmartTIVA has had to navigate FDA requirements, develop clinical and commercial partnerships, and secure funding to support growth. Fernandez credits mentors across Carey and Johns Hopkins Technology Ventures, including Christina Demur and Justin Berger at JHTV, and Josh Ambrose, Paul Davidson, Deja Robinson and Jake Dreier at the Pava Center. He also points to collaboration with Johns Hopkins anesthesiologist Kathryn Rosenblatt and Carey faculty members. Those connections have helped SmartTIVA engage with the wider Maryland startup ecosystem, including Johns Hopkins Technology Ventures, the Venture Mentoring Program, LaunchPort and TEDCO. Carey has also helped connect Fernandez’s entrepreneurial journey with other students. Laura Gomez, who worked with SmartTIVA before joining Carey, now works directly with the company. Fernandez says the Baltimore Innovation Initiative Grant will support a summer project for both of them, with the work expected to lead to a new patent. SCALING SMARTTIVA BEYOND THE CLASSROOM SmartTIVA is establishing the United States as its primary regulatory and commercial market, with plans to expand globally. The company has obtained two patents, established a U.S. corporate structure, and submitted a 510(k) application. Since its initial launch, SmartTIVA has sold to customers in more than 20 countries, including institutions such as Columbia University, Harvard University, and Children’s Hospital of Philadelphia. For Fernandez, the move to the United States meant starting over in some ways. He arrived with a functioning technology, but without a local network or deep familiarity with the U.S. business environment. Carey Business School provided a place to build those missing pieces through mentorship, coursework, and connections to entrepreneurs and organizations working to bring new ideas to market. His experience points to a practical role business schools can play in entrepreneurship: helping founders turn a promising product into a business with a strategy, network, and path to growth. Grounded in the Johns Hopkins legacy of excellence and research, we aren’t trapped by tradition. We’re inspired by it. At Johns Hopkins Carey Business School, we shape business leaders who seize opportunity, inspire change, and create lasting value. Whether full-time or part-time, in-person, online, or hybrid, our MBA and MS degrees in Baltimore and Washington, D.C. are data driven, built to compete in the global marketplace. Our faculty are thought-leaders, trailblazing what’s next in the business world and in the classroom. © Copyright 2026 Poets&Quants. All rights reserved. This article may not be republished, rewritten or otherwise distributed without written permission. To reprint or license this article or any content from Poets&Quants, please submit your request HERE.